Camire, Rodney M. http://orcid.org/0000-0002-0585-4537
Funding for this research was provided by:
National Heart, Lung, and Blood Institute (U54 HL142012, Project 4, P01 HL139420, Project 2)
Article History
Accepted: 13 April 2021
First Online: 22 April 2021
Declarations
:
: RMC is a consultant for and receives research support from Pfizer and Bayer. RMC also receives licensing fees for technology related to zymogen-like FXa.